Geng Hu
胡庚
Geng Hu (胡庚) is the co-founder of Qitan Technology, a Chinese nanopore gene-sequencing company backed by Gaorong Ventures — described in Gaorong's 2024 portfolio coverage as co-founder and CEO , and in earlier financing announcements as co-founder and chairman . By training he's an electronic-circuits specialist with a PhD from Tsinghua University, and he's described cross-disciplinary collaboration as one of Qitan's core moats . In his own telling, the company went from founding to completing R&D and product definition of China's first domestic nanopore sequencer in under five years, with mass production following in 2021 and a RMB 700 million Series C closed in 2022 to push commercialization . elsewhere's corpus doesn't cover him beyond these Gaorong-published financing and interview pieces, so personal background beyond the Tsinghua doctorate isn't available here.
AI-generated — may contain errors, please verify.
Coverage
Gaorong Ventures in Conversation with Hejeya and Qitan Tech: How Innovative Medical Devices "Cross the Razor's Edge"
"When you meet a mountain, you cut a path through it; when you meet a river, you build a bridge across it."
Qitan Tech Closes RMB 700 Million Series C Round to Advance Commercialization of Domestic Nanopore Sequencing Technology
Breaking Through the "Mass-Production No-Man's-Land" of Domestic Nanopore Sequencing
Qitan Tech Raises Over 400 Million Yuan in Series B, Leading the Nanopore Gene Sequencer Race
China's first fully self-developed nanopore gene sequencer is slated for mass production later this year.
Leading nanopore gene sequencing company **Qitan Technology** has raised over RMB 100 million in funding, led by Gaorong Ventures.
Focused on the independent R&D of nanopore gene sequencers, dedicated to making gene sequencing technology accessible to every household.
